{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:36:45Z","timestamp":1787726205692,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The aim was to estimate the risk of subsequent extra-cervical Human Papillomavirus (HPV) related cancer in patients surgically treated for high grade cervical intraepithelial neoplasia (CIN 2\u20133). This is the first study in Italy investigating the occurrence of extra-cervical tumors in this cohort of patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>3184 patients surgically treated for CIN2\u20133 since 1992 at the Department of Surgical Sciences of University of Torino were considered. The risk of HPV-related cancer was calculated as Standardized Incidence Ratio (SIR), using as expected values tumour age specific incidence of resident population.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>173\u2009second primary cancer (SCPs) were identified. SIR to develop cancer after treatment for CIN2\u20133 was 2.2 (CI 95% 1.89\u20132.50). Among these occurrences, 10 are in HPV related sites: 1 anus (SIR\u2009=\u20091.8; 0.04\u201310.0), 3 vagina (SIR\u2009=\u200912.4; 2.56\u201336.3), 1 vulva (SIR\u2009=\u20091.7; 0.04\u20139.59), 5 oropharynx (SIR\u2009=\u20098.5; 2.76\u201319.8).<\/jats:p>\n<jats:p>Significant risk has been also recorded for pulmonary (SIR\u2009=\u20093.1; 0.70\u20135.27) and bladder (SIR\u2009=\u20094.05; 1.10\u201310.56), with smoking as possible cofactor. We also found increased risk for breast (SIR\u2009=\u20092.4; 2.07\u20132.84) and ovarian cancers (SIR\u2009=\u20092.1; 1.13\u20133.49), probably due to an higher adherence to spontaneous and programmed screening programs.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our study supports the hypothesis of an increased risk of HPV-related tumours for CIN treated patients, mostly for CIN3. It is conceivable the need of early diagnosis for these cancers in this higher-risk populations.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-07452-6","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T13:03:57Z","timestamp":1602075837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Risk of HPV-related extra-cervical cancers in women treated for cervical intraepithelial neoplasia"],"prefix":"10.1186","volume":"20","author":[{"given":"Mario","family":"Preti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Libero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Sobrato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Busso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3041-1201","authenticated-orcid":false,"given":"Niccol\u00f2","family":"Gallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"7452_CR1","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet (London, England). 2007;370:890\u2013907. https:\/\/doi.org\/10.1016\/S0140-6736(07)61416-0.","journal-title":"Lancet (London, England)"},{"key":"7452_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2013.11.002","volume":"26","author":"M Tommasino","year":"2014","unstructured":"Tommasino M. The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol. 2014;26:13\u201321. https:\/\/doi.org\/10.1016\/j.semcancer.2013.11.002.","journal-title":"Semin Cancer Biol"},{"key":"7452_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","volume":"47","author":"S De Sanjos\u00e9","year":"2018","unstructured":"De Sanjos\u00e9 S, Brotons M, Pav\u00f3n MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2\u201313. https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.015.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"7452_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bpobgyn.2017.08.001","volume":"47","author":"J Doorbar","year":"2018","unstructured":"Doorbar J. Host control of human papillomavirus infection and disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:27\u201341. https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.001.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"7452_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","volume":"47","author":"B Serrano","year":"2018","unstructured":"Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14\u201326. https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.006.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"7452_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1136\/bmj.38663.459039.7C","volume":"331","author":"I Kalliala","year":"2005","unstructured":"Kalliala I, Anttila A, Pukkala E, Nieminen P. Risk of cervical and other cancers after treatment of cervical intraepithelial Neoplasia: retrospective cohort study. BMJ. 2005;331:1183\u20135. https:\/\/doi.org\/10.1136\/bmj.38663.459039.7C.","journal-title":"BMJ"},{"key":"7452_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.annonc.2019.11.004","volume":"31","author":"I Kalliala","year":"2020","unstructured":"Kalliala I, Athanasiou A, Veroniki AA, Salanti G, Efthimiou O, Raftis N, Bowden S, Paraskevaidi M, Aro K, Arbyn M, Bennett P, Nieminen P, Paraskevaidis E, Kyrgiou M. Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature. Ann Oncol. 2020;31:213\u201327.","journal-title":"Ann Oncol"},{"key":"7452_CR8","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1200\/JCO.2016.71.4543","volume":"35","author":"RMF Ebisch","year":"2017","unstructured":"Ebisch RMF, Rutten DWE, IntHout J, Melchers WJG, Massuger LFAG, Bulten J, et al. Long-lasting increased risk of human papillomavirus-related carcinomas and Premalignancies after cervical intraepithelial Neoplasia grade 3: a population-based cohort study. J Clin Oncol. 2017;35:2542\u201350. https:\/\/doi.org\/10.1200\/JCO.2016.71.4543.","journal-title":"J Clin Oncol"},{"key":"7452_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1470-2045(07)70043-8","volume":"8","author":"G Edgren","year":"2007","unstructured":"Edgren G, Spar\u00e9n P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol. 2007;8:311\u20136. https:\/\/doi.org\/10.1016\/S1470-2045(07)70043-8.","journal-title":"Lancet Oncol"},{"key":"7452_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ygyno.2014.07.088","volume":"134","author":"M Gaudet","year":"2014","unstructured":"Gaudet M, Hamm J, Aquino-Parsons C. Incidence of ano-genital and head and neck malignancies in women with a previous diagnosis of cervical intraepithelial neoplasia. Gynecol Oncol. 2014;134:523\u20136. https:\/\/doi.org\/10.1016\/j.ygyno.2014.07.088.","journal-title":"Gynecol Oncol"},{"key":"7452_CR11","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1158\/1055-9965.EPI-15-1291","volume":"25","author":"FL Sand","year":"2016","unstructured":"Sand FL, Munk C, Jensen SM, Svahn MF, Frederiksen K, Kj\u00e6r SK. Long-term risk for noncervical anogenital cancer in women with previously diagnosed high-grade cervical intraepithelial neoplasia: a Danish nationwide cohort study. Cancer Epidemiol Biomark Prev. 2016;25:1090\u20137. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-1291.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"7452_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/AOG.0b013e31820bfb16","volume":"117","author":"AM Saleem","year":"2011","unstructured":"Saleem AM, Paulus JK, Shapter AP, Baxter NN, Roberts PL, Ricciardi R. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm. Obstet Gynecol. 2011;117:643\u20139. https:\/\/doi.org\/10.1097\/AOG.0b013e31820bfb16.","journal-title":"Obstet Gynecol"},{"key":"7452_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ypmed.2016.06.041","volume":"90","author":"F Neumann","year":"2016","unstructured":"Neumann F, J\u00e9gu J, Mougin C, Pr\u00e9tet JL, Guizard AV, Lap\u00f4tre-Ledoux B, et al. Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: a population-based study. Prev Med (Baltim). 2016;90:52\u20138. https:\/\/doi.org\/10.1016\/j.ypmed.2016.06.041.","journal-title":"Prev Med (Baltim)"},{"key":"7452_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/LGT.0000000000000395","volume":"22","author":"AI Acevedo-Font\u00e1nez","year":"2018","unstructured":"Acevedo-Font\u00e1nez AI, Su\u00e1rez E, Torres Cintr\u00f3n CR, Ortiz AP. Risk of anal Cancer in women with a human papillomavirus-related gynecological neoplasm: Puerto Rico 1987-2013. J Low Genit Tract Dis. 2018;22:225\u201330. https:\/\/doi.org\/10.1097\/LGT.0000000000000395.","journal-title":"J Low Genit Tract Dis"},{"key":"7452_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/J.COVIRO.2017.07.014","volume":"26","author":"D Viarisio","year":"2017","unstructured":"Viarisio D, Gissmann L, Tommasino M. Human papillomaviruses and carcinogenesis: well-established and novel models. Curr Opin Virol. 2017;26:56\u201362. https:\/\/doi.org\/10.1016\/J.COVIRO.2017.07.014.","journal-title":"Curr Opin Virol"},{"issue":"Augus2019","key":"7452_CR16","doi-asserted-by":"publisher","first-page":"101649","DOI":"10.1016\/j.canep.2019.101649","volume":"64","author":"M Wang","year":"2020","unstructured":"Wang M, Sharma A, Osazuwa-peters N, Simpson MC, Schootman M, Piccirillo JF, et al. Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus ( HPV ) -associated cancers. Cancer Epidemiol. 2020;64(Augus2019):101649. https:\/\/doi.org\/10.1016\/j.canep.2019.101649.","journal-title":"Cancer Epidemiol"},{"key":"7452_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-015-1724-5","volume":"8","author":"A Testori","year":"2015","unstructured":"Testori A, Cioffi U, De Simone M, Bini F, Vaghi A, Lemos AA, et al. Multiple primary synchronous malignant tumors. BMC Res Notes. 2015;8:1\u20134. https:\/\/doi.org\/10.1186\/s13104-015-1724-5.","journal-title":"BMC Res Notes"},{"key":"7452_CR18","doi-asserted-by":"crossref","unstructured":"Pandey NO, Chauhan AV, Raithatha NS, Patel PK, Khandelwal R, Desai AN, Choxi Y, Kapadia RS, Jain ND. Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility. Sci Rep. 2019;9.","DOI":"10.1038\/s41598-019-55122-w"},{"key":"7452_CR19","first-page":"33","volume-title":"Monographs on the Evaluation of Carcinogenic Risks to Humans - Human Papillomaviruses. Vol. 90, International Agency for Research on Cancer Iarc","author":"Organization WHO, international agency for research on cancer humans ocrt","year":"2007","unstructured":"Organization WHO, international agency for research on cancer humans ocrt. Monographs on the Evaluation of Carcinogenic Risks to Humans - Human Papillomaviruses. Vol. 90, International Agency for Research on Cancer Iarc; 2007. p. 33\u201343."},{"issue":"2","key":"7452_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ygyno.2012.11.003","volume":"128","author":"P Luhn","year":"2013","unstructured":"Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA, Smith K, Mathews C, Allen RA, Zhang R, Wang S, Wentzensen N. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol. 2013;128(2):265\u201370. https:\/\/doi.org\/10.1016\/j.ygyno.2012.11.003.","journal-title":"Gynecol Oncol"},{"key":"7452_CR21","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel MW. Statistical aspects of thee analysis of data from retrospective studies of disease. J Nat Cancer Inst. 1959;22:719\u201348.","journal-title":"J Nat Cancer Inst"},{"key":"7452_CR22","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/bmj.39363.471806.BE","volume":"335","author":"B Strander","year":"2007","unstructured":"Strander B, Andersson-Ellstrom A, Milsom I, Sparen P. Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. Bmj. 2007;335:1077. https:\/\/doi.org\/10.1136\/bmj.39363.471806.BE.","journal-title":"Bmj"},{"key":"7452_CR23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1999","volume":"1","author":"R Suk","year":"2018","unstructured":"Suk R, Mahale P, Sonawane K, Sikora AG, Chhatwal J, Schmeler KM, Sigel K, Cantor S, Chiao EY, Deshmukh A. Trends in risks for second primary cancers associated with index human papillomavirus\u2013associated cancers. JAMA Netw Open. 2018;1:e181999. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.1999.","journal-title":"JAMA Netw Open"},{"key":"7452_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/medicina55070384","volume":"55","author":"SD Balasubramaniam","year":"2019","unstructured":"Balasubramaniam SD, Balakrishnan V, Ein Oon C, Kau G. Key molecular events in cervical Cancer development. Medicina. 2019;55:384. https:\/\/doi.org\/10.3390\/medicina55070384.","journal-title":"Medicina"},{"key":"7452_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ygyno.2020.01.030","volume":"157","author":"HK Bertoli","year":"2020","unstructured":"Bertoli HK, Thomsen LT, Iftner T, Dehlendorff C, Kj\u00e6r SK. Risk of vulvar, vaginal and anal high-grade intraepithelial Neoplasia and Cancer according to cervical human papillomavirus (HPV) status: a population-based prospective cohort study. Gynecol Oncol. 2020;157:456\u201362. https:\/\/doi.org\/10.1016\/j.ygyno.2020.01.030.","journal-title":"Gynecol Oncol"},{"key":"7452_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0090-8258(03)00231-2","volume":"90","author":"HS Evans","year":"2003","unstructured":"Evans HS, Newnham A, Hodgson SV, M\u00f8ller H. Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England. Gynecol Oncol. 2003;90:131\u20136. https:\/\/doi.org\/10.1016\/S0090-8258(03)00231-2.","journal-title":"Gynecol Oncol"},{"key":"7452_CR27","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/LGT.0b013e31825d2d7a","volume":"16","author":"S Tatti","year":"2012","unstructured":"Tatti S, Suzuki V, Fleider L, Maldonado V, Caruso R, Tinnirello MDLA. Anal intraepithelial lesions in women with human papillomavirus-related disease. J Low Genit Tract Dis. 2012;16:454\u20139. https:\/\/doi.org\/10.1097\/LGT.0b013e31825d2d7a.","journal-title":"J Low Genit Tract Dis"},{"key":"7452_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","volume":"27","author":"JD Carreon","year":"2007","unstructured":"Carreon JD, Sherman ME, Guill\u00e9n D, Solomon D, Herrero R, Jer\u00f3nimo J, Wacholder S, et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol. 2007;27:441\u20136. https:\/\/doi.org\/10.1097\/pgp.0b013e31805152ab.","journal-title":"Int J Gynecol Pathol"},{"key":"7452_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bpobgyn.2017.08.013","volume":"47","author":"TS Adams","year":"2018","unstructured":"Adams TS, Mbatani NH. Clinical Management of Women Presenting with field effect of HPV and intraepithelial disease. Best Practice & Research Clinical Obstetrics & Gynaecology. 2018;47:86\u201394. https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.013.","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"key":"7452_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/0284186X.2019.1581378","volume":"0","author":"LT Thomsen","year":"2019","unstructured":"Thomsen LT, Kj\u00e6r SK. Women with cervical cancer precursor lesions: a high-risk group for human papillomavirus (HPV)-related oropharyngeal cancer? Acta Oncol (Madr). 2019;0:1\u20132. https:\/\/doi.org\/10.1080\/0284186X.2019.1581378.","journal-title":"Acta Oncol (Madr)"},{"key":"7452_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41199-018-0039-3","volume":"3","author":"C Pan","year":"2018","unstructured":"Pan C, Issaeva N, Yarbrough WG. HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis. Cancers Head Neck. 2018;3:1\u201311. https:\/\/doi.org\/10.1186\/s41199-018-0039-3.","journal-title":"Cancers Head Neck"},{"key":"7452_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0123029","volume":"10","author":"N Pe\u00f1a","year":"2015","unstructured":"Pe\u00f1a N, Carrillo D, Mu\u00f1oz JP, Chnaiderman J, Urz\u00faa U, Le\u00f3n O, et al. Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6\/E7 for oxidative DNA damage in lung cells. PLoS One. 2015;10:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0123029.","journal-title":"PLoS One"},{"key":"7452_CR33","doi-asserted-by":"publisher","first-page":"96419","DOI":"10.18632\/oncotarget.21682","volume":"8","author":"WM Xiong","year":"2017","unstructured":"Xiong WM, Xu QP, Li X, Xiao RD, Cai L, He F. The association between human papillomavirus infection and lung cancer: a system review and meta-analysis. Oncotarget. 2017;8:96419\u201332. https:\/\/doi.org\/10.18632\/oncotarget.21682.","journal-title":"Oncotarget"},{"key":"7452_CR34","doi-asserted-by":"publisher","unstructured":"House R, Janakiraman H, Ogretmen B, Kato M, Erkul E, et al. Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer. 2018:1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0205077.","DOI":"10.1371\/journal.pone.0205077"},{"key":"7452_CR35","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/v7072802","volume":"7","author":"N Egawa","year":"2015","unstructured":"Egawa N, Egawa K, Griffin H, Doorbar J. Human papillomaviruses; epithelial tropisms, and the development of Neoplasia. Viruses. 2015;7:3863\u201390. https:\/\/doi.org\/10.3390\/v7072802.","journal-title":"Viruses"},{"key":"7452_CR36","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/cncr.11191","volume":"97","author":"HL Chiou","year":"2003","unstructured":"Chiou HL, Wu MF, Liaw YC, Cheng YW, Wong RH, Chen CY, Lee H. The presence of human papillomavirus type 16\/18 DNA in blood circulation may act as a risk marker of lung Cancer in Taiwan. Cancer. 2003;97:1558\u201363. https:\/\/doi.org\/10.1002\/cncr.11191.","journal-title":"Cancer"},{"key":"7452_CR37","doi-asserted-by":"publisher","unstructured":"Fox-Lewis A, Allum C, Vokes D, Roberts S. Human papillomavirus and surgical smoke: a systematic review. Occup Environ Med. 2020. https:\/\/doi.org\/10.1136\/oemed-2019-106333.","DOI":"10.1136\/oemed-2019-106333"},{"key":"7452_CR38","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.biopha.2018.06.149","volume":"106","author":"RP Araldi","year":"2018","unstructured":"Araldi RP, Sant\u2019Ana TA, M\u00f3dolo DG, de Melo TC, Spadacci-Morena DD, de Cassia SR, et al. The human papillomavirus (HPV)-related cancer biology: an overview. Biomed Pharmacother. 2018;106:1537\u201356. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.149.","journal-title":"Biomed Pharmacother"},{"key":"7452_CR39","doi-asserted-by":"publisher","unstructured":"Balci FL, Uras C, Feldman SM. Is human papillomavirus associated with breast cancer or papilloma presenting with pathologic nipple discharge? Cancer Treat Res Commun. 2019;19. https:\/\/doi.org\/10.1016\/j.ctarc.2019.100122.","DOI":"10.1016\/j.ctarc.2019.100122"},{"key":"7452_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-016-1442-2","volume":"16","author":"I Cromwell","year":"2016","unstructured":"Cromwell I, Gaudet M, Peacock SJ, Aquino-Parsons C. Cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in British Columbia, Canada. BMC Health Serv Res. 2016;16:1\u201310. https:\/\/doi.org\/10.1186\/s12913-016-1442-2.","journal-title":"BMC Health Serv Res"},{"key":"7452_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cncy.20126","volume":"119","author":"TM Darragh","year":"2011","unstructured":"Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol. 2011;119:5\u201319. https:\/\/doi.org\/10.1002\/cncy.20126.","journal-title":"Cancer Cytopathol"},{"key":"7452_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4149\/neo","volume":"62","author":"J Slama","year":"2015","unstructured":"Slama J, Sehenal B, Dusek L, Zima T, Cibula D. Impact of risk factors on prevalence of anal HPV infection in women with simultaneous cervical lesion. Neoplasma. 2015;62:2. https:\/\/doi.org\/10.4149\/neo.","journal-title":"Neoplasma"},{"key":"7452_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pvr.2017.12.001","volume":"5","author":"ED Ehrenpreis","year":"2018","unstructured":"Ehrenpreis ED, Smith DG. Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: results of a pilot study using a STELLA computer simulation and economic model. Papillomavirus Res. 2018;5:38\u201345. https:\/\/doi.org\/10.1016\/j.pvr.2017.12.001.","journal-title":"Papillomavirus Res"},{"key":"7452_CR44","doi-asserted-by":"publisher","unstructured":"Wells J, Flowers L, Sudeshna P, Minh LN, Anjali S, Marcia H. Knowledge of Anal Cancer , Anal Cancer Screening , and HPV in HIV-Positive and High-Risk HIV-Negative Women. J Cancer Educ. 2019. https:\/\/doi.org\/10.1007\/s13187-019-01503-8.","DOI":"10.1007\/s13187-019-01503-8"},{"key":"7452_CR45","doi-asserted-by":"crossref","unstructured":"Ramos-Cartagena JM, P\u00e9rez CM, Guiot HM, Amaya-Ardilla CP, Tirado-G\u00f3mez M, Ortiz AP. Assessment of Anal Cancer Screening Tools in Detecting High-Grade Anal Squamous Intraepithelial Lesions in Women. J Low Genit Tract Dis 2020 Jan;24(1):75\u201381. doi: 10.1097\/LGT.0000000000000497.","DOI":"10.1097\/LGT.0000000000000497"},{"key":"7452_CR46","first-page":"65","volume":"15-36","author":"R Beaglehole","year":"1997","unstructured":"Beaglehole R, Bonita R, Kjellstr\u00f6m T. Epidemiologia di base. 1997;15-36:65\u201382.","journal-title":"Epidemiologia di base"},{"issue":"5","key":"7452_CR47","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/AOG.0000000000003833","volume":"135","author":"K Lichter","year":"2020","unstructured":"Lichter K, Krause D, Xu J, Tsai SHL, Hage C, Weston E, Eke A, Levinson K. Adjuvant human papillomavirus vaccine to reduce recurrent cervical dysplasia in unvaccinated women: a systematic review and meta-analysis. Obstet Gynecol. 2020 May;135(5):1070\u201383. https:\/\/doi.org\/10.1097\/AOG.0000000000003833.","journal-title":"Obstet Gynecol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07452-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T02:09:33Z","timestamp":1633572573000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07452-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7452"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07452-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"13 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the istitutional review board (IRB) of the Department of Surgical Sciences University of Torino, Italy and written consent was obtained from each participant according to Declaration of Helsinki. Researchers conducted the study using newly assigned identification number and personal information was removed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"972"}}